The changes in leadership brought about by the November midterm elections are likely to result in significant shifts in the way Congress approaches health policy issues, according to several experts.
One change that many physicians are hoping the new Democratic leadership will make is to fix the Medicare physician payment formula.
Under the current payment formula, physicians are facing a 5% payment cut in January. “For the immediate future, we are asking that they cancel the cut and give physicians a positive [payment increase] to reflect inflation, which is slightly over 2%,” Dr. Cecil Wilson, chair of the American Medical Association board of trustees, said in an interview at press time.
Such an immediate fix would not address the underlying problem: that the physician fee schedule relies on the flawed Sustainable Growth Rate (SGR).
“Congress needs to do a permanent fix to this problem,” said Dr. Wilson, an internist in Winter Park, Fla. “We will be working very hard on that for this coming year, to ask that they get rid of this formula and move to one that reflects the increased cost of providing care.”
Ron Pollack, who is executive director of Families USA, a liberal consumer group that is based in Washington, voiced optimism that the new Congress would look at the payment formula.
“I think the Democrats probably do want to deal with that–whether it will be on a year-by-year basis or on a more permanent basis, I don't know,” he said in an interview. “But I do think the Democrats are inclined to get that fixed.”
Malpractice reform could be another story, Mr. Pollack said.
“The one and perhaps only way that issue is going to move forward will be if there is significant compromise,” Mr. Pollack said. “[The strategy of] placing caps on damage awards probably makes it difficult to move this forward. On the other hand, to the extent that alternative conflict resolution systems are established that substantially reduce litigation and provide more people with access to grievance mechanisms short of legal proceedings, that certainly has a chance of movement.”
Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank in Washington, was even more negative.
Malpractice reform “is not going anywhere and that's a welcome development, because the Constitution doesn't give Congress any authority to play any role in that area,” he said.
“The Republicans never recognized that, but the Democrats, in this instance, are in favor of letting the states deal with that issue, and they are not interested in any federal malpractice reforms,” Mr. Cannon said.
Covering the uninsured is another area that could move to the front burner under the Democrats, Dr. Wilson said.
“We now know that [the uninsured] are more likely to get sicker and die sooner” than those with insurance, he said. “We'll be trying to increase the visibility of that problem.”
One definite health care priority for Rep. Nancy Pelosi (D-Calif.), who will become Speaker of the House in January, will be to get rid of a prohibition in the Medicare prescription drug coverage law that prevents the Centers for Medicare and Medicaid Services from negotiating prices directly with pharmaceutical companies.
“We can and we must make the Medicare prescription drug plan fairer and more cost effective,” Rep. Pelosi said in a statement.
Removal of that prohibition would be a welcome change, according to Mr. Pollack, of Families USA. By bargaining directly with drug companies, the Department of Veterans Affairs “has achieved much lower prices than the lowest prices charged by all Medicare Part D plans,” he said in a statement, noting that the median price difference was 46%.
Cato's Mr. Cannon had a different take on the idea. “Democrats are attracted to price controls because it allows them to provide a benefit for current generations through lower cost drugs, while imposing a cost on future generations, which is fewer new drugs being developed” due to declining revenues for pharmaceutical companies, he said.
Another thing the Democrats will consider doing with the Part D plan is to close up the doughnut hole–the gap in coverage beneficiaries have when their drug bills exceed a certain amount. Rep. Pelosi has said she plans to do this using the savings achieved through letting Medicare negotiate drug costs directly.
Analysts are anticipating a new direction in health policy in the new Congress because the presumed new chairs of the committees and subcommittees dealing with health care are considered quite liberal.
This group includes Rep. Charles Rangel (D-N.Y.), who is expected to head the Ways and Means Committee; Rep. John Dingell (D-Mich.), expected to head the Energy and Commerce Committee; Rep. George Miller (D-Calif.), expected to become chariman of the Education and Workforce Committee; and Rep. Fortney H. “Pete” Stark (D-Calif.), expected to head the Ways and Means health subcommittee.